Fig. 8.
Fig. 8. Mice receiving Tyr177Phe bcr/abl-transduced BM develop T-ALL. / (A) FACS analysis of peripheral blood from Tyr177Phe bcr/abl mouse (no. 2) at day 99 after BMT. The WBC count was 11 × 106cells/mL. (B) FACS analysis of the tumor mass from the same ill Tyr177Phe bcr/abl mouse. The tumor cells were GFP+CD4+CD8+.

Mice receiving Tyr177Phe bcr/abl-transduced BM develop T-ALL.

(A) FACS analysis of peripheral blood from Tyr177Phe bcr/abl mouse (no. 2) at day 99 after BMT. The WBC count was 11 × 106cells/mL. (B) FACS analysis of the tumor mass from the same ill Tyr177Phe bcr/abl mouse. The tumor cells were GFP+CD4+CD8+.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal